Specialty pharmaceutical co appoints Robert Rosen to its board

By Admin
A.P. Pharma Inc said it has appointed Robert Rosen to its board of directors, the news reports said. Kevin C Tang , A.P. Pharmas Chairman of the board...

A.P. Pharma Inc said it has appointed Robert Rosen to its board of directors, the news reports said.

Kevin C Tang , A.P. Pharma’s Chairman of the board said, “We are delighted that Robert has chosen to join the A.P. Pharma board. Robert’s particular expertise in commercializing oncology drugs will be instrumental, as we enter the commercialization phase with our lead product, APF530, for preventing both acute and delayed-on set chemotherapy-induced nausea and vomiting.” 

Mr. Rosen is the Managing Partner of Scotia Nordic LLC. He has also served as the global head of oncology at BayerHealthCare from 2005 to 2011, where he was responsible to develop the oncology business unit for regions including the Europe, America, Japan and Asia Pacific.

During his tenure at Bayer HealthCare, he also led the launch of Nexavar to treat renal cell carcinmoma and hepatocellular carcinoma.

From period, 2002-2005, Mr. Rosen was also the Vice President of the oncology business unit at Sanofi Synthelabo, where he was responsible to develop Sanofi’s U.S.oncology business and the launch of Eloxatin for colon cancer.  

A.P. Pharma also said that it has appointed Kevin C Tang as Chairman of the board and Paul Goddard, PH.D. and Gregory Turnbull has resigned from the board.

It is a specialty pharmaceutical company that develops products using its proprietary biochronomer polymer-based drug delivery platform.



Featured Articles

Oracle's generative AI prioritises patient healthcare

Oracle's vision for better healthcare focuses on improving medical professionals quality time with patients, with Oracle Clinical Digital Assistant

2San's new app provides vital diagnostic product insights

2San’s leap forward in self diagnostics will bring ‘Better Care, Better Life’ to all, in a new step for 2San’s post-COVID-19 healthcare technology

Cylera’s Richard Staynings on healthcare cybersecurity

Richard Staynings, Chief Security Strategist, discusses the challenges facing healthcare cybersecurity & how Cylera's IoT security can protect it

Amazon Prime & One Medical to revolutionise healthcare

Digital Healthcare

Creating robust pharma supply chains with delivery devices

Medical Devices & Pharma

From Ukraine to Myanmar, reports reveal attacks on hospitals